Cancer Vaccines: A Dose of Prevention
Webinar

Cancer Vaccines: A Dose of Prevention

Discover the latest progress behind therapeutic vaccines that boost the immune system’s cancer-killing abilities.

Share

This webinar will be hosted live and available on-demand

Thursday, September 21, 2023 
11:30 AM Eastern Time 

Vaccines offer scientists and clinicians the ability to enhance or modulate the immune system, which carries unique promise for cancer treatment. Whether targeting the inherent tumor-killing abilities of immune cells or improving efficacy of established immunotherapies, researchers work towards therapeutic vaccines that boost the anticancer immune system.

In this webinar brought to you by The Scientist, Denise Cecil and James Gulley will share new progress in the cancer vaccine field. They will highlight the scientific rationale behind these preventatives, explain which cancers are the primary targets, and discuss the main obstacles to cancer vaccine implementation.

Topics to be covered 

  • The role that therapeutic vaccines play when paired with immunotherapy 
  • The latest clinical trial data on therapeutic vaccines for multiple forms of cancer
Denise

Denise Cecil, PhD 
Principal Scientist
Cancer Vaccine Institute
University of Washington

James L. Gulley, MD, PhD

James L. Gulley, MD, PhD 
Senior Investigator
Co-Director, Center for Immuno-Oncology
Deputy Director, Center for Cancer Research 
Clinical Director, National Cancer Institute



Top Image Credit:

Cancer Vaccines: A Dose of Prevention

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies